Non-enzymatic glycosylation reaction contributes to a rise of blood glucose in alloxan-induced diabetic rats

International Journal of Diabetes and Metabolism

Volumn 15, Issue 2, 2007, Pages 52-59

  Zhang, Zhicai ^a   Cui, Feng Jie ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

EMP pathway; Glycosylated haemoglobin; Non enzymatic glycosylation reaction; Respiration chain; TCA pathway; Total haemoglobin; Tremella aurantialba

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; INSULIN; ISOCITRATE DEHYDROGENASE; MALATE DEHYDROGENASE; METFORMIN; OXOGLUTARATE DEHYDROGENASE; OXYGEN; PLANT EXTRACT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SUCCINATE DEHYDROGENASE; TREMELLA AURANTIALBA EXTRACT; TREMELLA AURANTIALBA POLYSACCHARIDE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENZYME ACTIVITY; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCOLYSIS; GLYCOSYLATION; HEMOGLOBIN BLOOD LEVEL; HYPERGLYCEMIA; IC 50; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; MEDICINAL PLANT; NONHUMAN; OXYGEN SUPPLY; RAT; RESPIRATORY CHAIN; TREATMENT DURATION; TREMELLA AURANTIALBA;

EID: 46149092263     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025 prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-1431.
2. Boyle JP, Honeycutt AA. Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care 2001; 24: 1936-1940.
3. Reshetnikov SV, Wasser SP, Tan KK. Higher basidiomycota as a source of antitumor and immunostimulating polysaccharides. Int J Med Mushr 2001; 3: 361-394.
4. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biot 2002; 60: 258-274.
5. Kiho T, Kochi M, Usui S, et al. Antidiabetic effect of an acidic polysaccharide (TAP) from Tremella aurantia and its degradation product (TAP-H). Biol Pharm Bull 2001; 24: 1400-1403.
6. Lo HC, Yang JG, Liu BC, et al. The effects of Tremella aurantiaia on testosterone and corticosterone productions in normal and diabetic rats. Arch Androl 2004; 50: 395-404.
7. Zhang W, Qu WJ, Zhang XL, et al. The anti-hyperglycemic activity of polysaccharides from Tremella aurantialba mycelium. Acta Nutrimenta Sinica 2004; 26: 300-303.
8. Wang H, Qu WJ, Chu SD, et al. Studies on the preventive and therapeutic effects of the polysaccharide of Tremella aurantialba mycelia on diet-induced hyperlipidemia in Mice. Acta Nutrimenta Sinica 2002; 24: 431-433.
9. Kiho T, Morimoto H, Kobayashi T, et al. Effect of a polysaccharide (TAP) from the fruiting bodies of Tremella aurantia on glucose metabolism in mouse liver. Biosci Biotech Biochem 2000; 64: 417-419.
10. Li XH, Yang LL, Zhu SF. Tremella aurantialba on immunnocompetence in mice. J Shanxi Med Univ 2000; 3: 206-207.
11. Texier O, Pourrat H, Pourrat A, Barthomeuf C. Purification of fićaria saponins by Saccharomyces beticus, penicillium rugulosum and Aspergillus niger. Biotechnology Lett (Historical Archive) 1984; 6: 243-246.
12. Miller GL. Use of dinitrosalicylic acid reagent for determination of reducing sugars. Anal Chem 1959; 31: 426-428.
13. Joyce PF, Sanford C. Quantitation of sputum protein by use of the Biuret reaction. Clin Chem 1970; 16: 773-775.
14. Wu CC, Huang CM, Lin CH, Ho YS, Chen CM, Lee HM. Advanced glycosylation end products induce NF-KB dependent iNOS expression in RAW264.7 cells. Mol Cell Endocrinol 2002; 194: 9-17.
15. Drabkin DL, Austin JM. Spectrophotometric constants for common haemoglobin derivatives in human, dog and rabbit blood. J Biol Chem 1932; 98: 719-733.
16. Sudhakar NS, Pattabiraman TN. A new colorimetric method for the estimation of glycosylated haemoglobin. Clin Chem Acta 1981; 109: 267-274.
17. Bannon P, Joly JG, Lessard F, Lepage R. Comparison of three methods for the elimination of the labile fraction of HbA1. Clin Biochem 1985; 18: 114-117.
18. Xu YJ, Wu XQ, Liu W, et al. A convenient assay of glycoserum by nitroblue tetrazolium with iodoacetamide. Clin Chim Acta 2002; 325: 127-131.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
20. Branstrup N, Krik JE, Bruni C. The hexokinase and phosphogluco isomerase activities of aorta and pulmonary artery tissue in individuals of various ages. J Gerontol B-Psychol 1957; 12: 166-171.
21. Seymour, AML, John CC. The Effects of hypertrophy and diabetes on cardiac pyruvate dehydrogenase Activity. J Mol Cell Cardiol 1997; 29: 2771-2778.
22. Johnson D, Lordy H. Isolation of liver and kidney mitochondria. Method Enzymol 1967; 10: 94-96.
23. King J. The hydrolases acid and alkaline phosphatase. In: Practical Clinical Enzymology. Van D, Ed. London, Nortstand Company Ltd. 1965: 191-208.
24. Reed LJ, Mukherjee BB. α-Ketoglutarate dehydrogenase complex from Escherichia coli. Method Enzymol 1969; 13: 55-61.
25. Slater EC, Bonner WD. Effect of fluoride on succinate oxidase system. Biochem J 1952; 52: 185-196.
26. Mehler, H. Kornberg A, Grisolia S, Ochoa S. The enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvate. J Biol Chem 1948; 714: 961-977.
27. Minakami S, Ringer RL, Singer TJP. Studies on respiratory chainlinked dihydrodiphosphopyridine nucleotide dehydrogenase. J Biol Chem 1962; 237: 569-576.
28. Wharton C, Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Method Enzymol 1967; 10: 245-250.
29. Guntinas MB, Wissiack R, Bordin G, Rodriguez AR. Determination of haemoglobin Alc by liquid chromatography using a new cation-exchange column. J Chromatogr B 2003; 791: 73-83.
30. John WB. Pyridoxamine, a versatile inhibitor of advanced glycation and lipoxidation reactions. International Congress Series 2002; 1245: 31-35.
31. Thoresen SI, Bredal WP. Determination of a reference range for fructosamine in feline serum samples. Vet Res Commun 1995; 19: 353-361.
32. Qing Q, Sirkku KK, Esa I. The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol 1997; 50: 153-158.
33. Watala C, Jacek G, Henryk W, et al. The effects of in vivo and in vitro non-enzymatic glycosylation and glycoxidation on physico-chemical properties of haemoglobin in control and diabetic patients. Int J Biochem Cell Biol 1996; 28: 1393-1403.
34. Ashokkumar N, Leelavinothan P. Effect of N-benzoyl-d-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 2005; 351: 105-113.
35. Pari L, Amarnath MS. Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats. Life Sci 2006; 79: 641-645.
36. Ngozi HU, Cynthia LF. Modulation of the flux patterns in carbohydrate metabolism in the livers of streptozoticin-induced diabetic rats by dietary caloric restriction. Pharm Res 2006; 54: 172-180.
37. John CC, Seymour AML. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res 2002; 55: 104-112.
38. Ashokkumar N, Leelavinothan P. Effect of N-benzoyl-d-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 2005; 351: 105-113.
39. Panneerselvam RS, Govindaswamy S. Effect of sodium molybdate on carbohydrate metabolizing enzymes in alloxan-induced diabetic rats. J Nutr Biochem 2002; 13: 21-26.
40. Brignone JA, de Brignone CM, Ricci CR, et al. Favourable, significant effect of dose-dependent treatment with 38486 (RU) on the alterations of the hepatic mitochondrial function of diabetic rats. Diabetes Res Clin Pract 1996; 32: 141-148.
41. Kristal BS, Jackson CT, Chung HY, Matsuda M, Nguyen HD, Yu BP. Defects at center P underlie diabetes-associated mitochondrial dysfunction. Free Radical Bio Med 1997; 22: 823-833.
42. Reiser KM. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med 1991; 196: 17-29.
43. Ruderman NR, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992; 6: 2905-2914.
44. Horiuchi S, Higashi T, Ikeda K, Saishoji T, Jinnouchi Y, Sano H, et al. Advanced glycation end products and their recognition by macrophage and macrophage-derived cells. Diabetes 1996; 45: 73-76.
45. Dean RT. Lysosomal enzymes as agents of turnover of soluble cytoplasmatic proteins. Eur J Biochem 1975; 58: 9-14.
46. Samaja M, Melotti D, Carenini A, Pozza G. GHbs and the oxygen affinity of whole blood. Diabetologia 1982; 23: 399-402.
47. Vanboekel MA. The role of glycation in aging and diabetes mellitus. Mol Biol Rep 1991; 15: 57-64.
48. Peter AM. Bioenergentics and the metabolism of carbohydrates and lipids. In: Harper's Biochemistry, 25th Robert KM, Daryl KG, Victor WR Eds. Science Publishing Company, Beijing, China. 2000: 182-208.
49. Panneerselvam RS, Govindaswamy S. Lower Intraocular Oxygen Tension in Diabetic Patients: Possible Contribution to Decreased Incidence of Nuclear Sclerotic Cataract. Am J Ophthalmol 2006; 141: 1027-1032.
50. Lashin O, Andrea R. Mitochondria respiration and susceptibility to ischemia-reperfusion injury in diabetic hearts. Arch Biochem Biophys 2003; 420: 298-304.
51. Noda M, Yamashita S, Takahashi N, Eto K, Shen LM, Izumi K, et al. Switch to Anaerobic Glucose Metabolism with NADH Accumulation in the β-Cell Model of Mitochondrial Diabetes. J Biol Chem 2002; 277: 41817-41826.